Loading grant details…
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
| Funder | National Institutes of Health |
|---|---|
| Recipient Organization | Not specified |
| Country | USA |
| Start Date | Sep 18, 2024 |
| End Date | Dec 05, 2028 |
| Duration | 1,539 days |
| Number of Grantees | 1 |
| Data Source | Grants.gov |
| Grant ID | 14a56590-38c0-4e5e-8202-117a9297aa35 |
Grant Description
This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain.
The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program.
The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).
All Grantees
To be determined
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Related Grants
